Ginkgo Bioworks (NYSE:DNA) Price Target Cut to $6.00

Ginkgo Bioworks (NYSE:DNA – Get Rating) had its price target lowered by analysts at BTIG Research from $12.00 to $6.00 in a research report issued to clients and investors on Thursday, The Fly reports. BTIG Research’s price objective suggests a potential upside of 42.18% from the company’s previous close. Other research analysts also recently issued […]

Related Keywords

United States ,America ,Raymond James ,Penserra Capital Management ,Eagle Acquisition Corp ,Zacks Investment Research ,Manufacturers Life Insurance Company ,Goldman Sachs Group ,Blackrock Inc ,Parametric Portfolio Associates ,Ginkgo Bioworks ,Get Rating ,Portfolio Associates ,Capital Management ,Soaring Eagle Acquisition Corp ,Nyse Dna ,Dna ,Medical ,Lower Price Target ,Btig Research ,